Trials / Active Not Recruiting
Active Not RecruitingNCT06649773
The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients
A Study to Evaluate the Efficacy and Safety of Noiiglutide Injection in Type 2 Diabetes Patients Who Received Metformin in Combination With or Without Another Oral Hypoglycemic Drug for Poor Blood Glucose Control -- a Phase III Clinical Trial of Multicenter, Randomized, Double-blind, Placebo Parallel Control
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 137 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to confirm that SHR20004 is more effective than placebo in controlling blood glucose in patients with type 2 diabetes. Evaluate the efficacy, safety, and pharmacokinetics of SHR20004 after 24 weeks of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Noiiglutide Injection | Experimental group |
| DRUG | Noiiglutide Placebo | Placebo Comparator group |
Timeline
- Start date
- 2024-10-25
- Primary completion
- 2025-05-28
- Completion
- 2025-09-30
- First posted
- 2024-10-21
- Last updated
- 2025-08-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06649773. Inclusion in this directory is not an endorsement.